0

543500

EVOQ

img img img img
No Data Available

Evoq Remedies Limited Share Price Update

As of the latest trading session, Evoq Remedies Limited share price is currently at ₹3, which is down by ₹-0.22 from its previous closing. Today, the stock has fluctuated between ₹2.95 and ₹3.27. Over the past year, Evoq Remedies Limited has achieved a return of -16.43%. In the last month alone, the return has been -3.84%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Evoq Remedies Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    7.50

  • P/E Ratio (TTM)

    75.00

  • Beta

    0.74

  • Book Value / share

    17.88

  • Return on equity

    0.26%

  • EPS (TTM)

    0.04

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Evoq Remedies Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 11.76
Operating Expense 14.04
Net Profit 0.09
Net Profit Margin (%) 0.76
Earnings Per Share (EPS) 0.04
EBITDA 0.18
Effective Tax Rate (%) 30.76
Particulars MAR 2024 (Values in Cr)
Revenue 4.05
Operating Expense 5.70
Net Profit 0.45
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 0.33
EBITDA 0.62
Effective Tax Rate (%) 26.22
Particulars MAR 2023 (Values in Cr)
Revenue 20.39
Operating Expense 24.13
Net Profit 1.62
Net Profit Margin (%) 7.94
Earnings Per Share (EPS) 1.19
EBITDA 2.28
Effective Tax Rate (%) 29.38
Particulars MAR 2022 (Values in Cr)
Revenue 16.78
Operating Expense 15.32
Net Profit 1.09
Net Profit Margin (%) 6.49
Earnings Per Share (EPS) 0.70
EBITDA 1.46
Effective Tax Rate (%) 25.34
Particulars MAR 2021 (Values in Cr)
Revenue 10.02
Operating Expense 9.07
Net Profit 0.72
Net Profit Margin (%) 7.18
Earnings Per Share (EPS) 71.55
EBITDA 0.95
Effective Tax Rate (%) 25.26
Particulars MAR 2025 (Values in Cr)
Book Value / Share 17.89
ROE % 0.26
ROCE % 0.35
Total Debt to Total Equity 0.06
EBITDA Margin 1.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 18.56
ROE % 1.80
ROCE % 1.91
Total Debt to Total Equity 0.28
EBITDA Margin 15.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 18.22
ROE % 6.76
ROCE % 6.97
Total Debt to Total Equity 0.37
EBITDA Margin 11.23
Particulars MAR 2022 (Values in Cr)
Book Value / Share 17.03
ROE % 9.12
ROCE % 9.11
Total Debt to Total Equity 0.34
EBITDA Margin 8.70
Particulars MAR 2021 (Values in Cr)
Book Value / Share 743.02
ROE % 189.47
ROCE % 249.35
Total Debt to Total Equity 0.01
EBITDA Margin 9.48
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.21
Total Assets 50.00
Total Liabilities 50.00
Total Equity 44.53
Share Outstanding 2
Price to Book Ratio 0.14
Return on Assets (%) 0.17
Return on Capital (%) 0.2
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 36.86
Total Liabilities 36.86
Total Equity 25.23
Share Outstanding 1
Price to Book Ratio 0.47
Return on Assets (%) 1.22
Return on Capital (%) 1.53
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.15
Total Assets 34.89
Total Liabilities 34.89
Total Equity 24.78
Share Outstanding 1
Price to Book Ratio 0.71
Return on Assets (%) 4.64
Return on Capital (%) 4.71
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 3.09
Total Assets 33.33
Total Liabilities 33.33
Total Equity 23.16
Share Outstanding 1
Price to Book Ratio 1.33
Return on Assets (%) 3.27
Return on Capital (%) 3.48
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 8.04
Total Liabilities 8.04
Total Equity 0.74
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 8.89
Return on Capital (%) 96.13
Particulars MAR 2025 (Values in Cr)
Net Income 0.12
Cash from Operations -14.58
Cash from Investing -0.25
Cash from Financing 14.97
Net change in Cash 0.09
Free Cash Flow -14.32
Particulars MAR 2024 (Values in Cr)
Net Income 0.61
Cash from Operations 5.47
Cash from Investing -0.01
Cash from Financing -5.33
Net change in Cash -0.03
Free Cash Flow 5.49
Particulars MAR 2023 (Values in Cr)
Net Income 2.28
Cash from Operations -3.67
Cash from Investing -0.01
Cash from Financing 1.41
Net change in Cash -2.94
Free Cash Flow -3.66
Particulars MAR 2022 (Values in Cr)
Net Income 1.45
Cash from Operations -26.05
Cash from Investing 0.00
Cash from Financing 29.49
Net change in Cash 3.06
Free Cash Flow -26.05
Particulars MAR 2021 (Values in Cr)
Net Income 0.71
Cash from Operations 0.03
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.03
Free Cash Flow 0.03
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 688.85 31.43 4.06 24178.64 639.50 / 946.50
KOTHARI INDUSTRIAL CORPORATION 179.30 0.00 7.09 1936.83 106.85 / 624.95
OSWAL AGRO MILLS LTD 47.41 7.34 0.65 636.38 45.00 / 110.69
DHUNSERI VENTURES LIMITED 245.05 0.00 0.26 858.17 242.10 / 402.00
RAMA PETROCHEMICALS LTD. 14.63 0.00 -0.31 19.49 9.93 / 14.63
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 688.85 37.50 8.78 24178.64 639.50 / 946.50
UTIQUE ENTERPRISES LIMITED 4.48 7.23 0.34 24.94 3.77 / 6.40
COMPUTER POINT LTD. 4.17 0.00 0.38 12.51 3.70 / 6.79
KOTHARI INDUSTRIAL CORPORATION 179.30 0.00 7.08 1936.83 106.85 / 624.95

Evoq Remedies Limited shareholding pattern

Holding

88.78%
11.21%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Evoq Remedies Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
3.00 -6.83 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 3.10
  • 26 Days 3.10
  • 10 Days 3.10
  • 50 Days 3.20
  • 12 Days 3.10
  • 100 Days 3.50
  • 20 Days 3.10
  • 200 Days 4.10
3.18 PIVOT

First Support

3.13

First Resistance

3.26

Second Support

3.05

Second Resistance

3.31

Third Support

3.00

Third Resistance

3.39

RSI

43.08

ADX

13.22

MACD

0.00

Williams % R

-76.92

Commodity Channel Index (CCI)

-38.42

Date

2026-02-27

Week

57600.00

Same Day

184000.00

Month

41833.00

1 Year

0.75

3 Year

0.61

Over 1 Month

-3.84%

down

Over 1 Year

-16.43%

down

Over 3 Months

-6.54%

down

Over 3 Years

-38.42%

down

Over 6 Months

-3.22%

down

Over 5 Years

0.00%

down

Evoq Remedies Limited Corporate Actions

Top Gainers

Evoq Remedies Limited Share Price

Evoq Remedies Limited was originally incorporated as 'Salus Life Science and Research Private Limited' at Ahmedabad, Gujarat on February 24th, 2010 vide Certificate of Incorporation issued by Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli. Subsequently, name of the Company was changed to 'Evoq Remedies Private Limited' on July 15th, 2019 and upon its conversion into Public Company, the name was changed to 'Evoq Remedies Limited' dated July 28th, 2021.

Although Company was formed in 2010, it started operations from 2018 onwards. Company is a recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to customers located in Ahmedabad. Company is engaged in pharmaceutical business involving marketing, trading and distribution of pharmaceutical formulation products such as antibiotic drugs, antimalarial drugs, antiallergic & anti cold drugs, analgesic/ antipyretic & anti inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants and injections.

The Company offer wide range of pharmaceuticals formulation products, of which around 120 products are marketed by them under their own brand name, the manufacturing of which is outsourced by them to third parties. Apart from pharmaceutical formulation products, we also deal in trading of active pharmaceutical ingredients (API's).

In areas like Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., Company specializes in offering quality products and affordable trading in Gujarat. In the healthcare segment, the Company being into trading business, hence offers a wide basket of products. These pharmaceutical raw materials include both active pharmaceutical ingredients (APIs) and inactive ingredients or excipients.

The Company made a public issue by allotting 36,00,000 equity shares and raised funds aggregating to Rs. 9.72 Crore in March, 2022.

Parent organization Indian Private
NSE symbol [-]
Founded 2010
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Evoq Remedies Ltd?

Answer Field

Evoq Remedies Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 3.00 as on Feb 27 2026 02:35 PM.

What is the Market Cap of Evoq Remedies Ltd Share?

Answer Field

The market cap of Evoq Remedies Ltd for NSE ₹ 0.00 & for BSE ₹ 7.50 as on Feb 27 2026 02:35 PM.

What is the 52 Week High and Low of Evoq Remedies Ltd?

Answer Field

The 52 Week High and Low of Evoq Remedies Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 6.11 and ₹ 2.11.

What is 1 year return for Evoq Remedies Ltd?

Answer Field

The 1 year returns on the stock has been -16.43%.

What is the P/E Ratio of Evoq Remedies Ltd Share?

Answer Field

As on Feb 27 2026 02:35 PM the price-to-earnings (PE) ratio for Evoq Remedies Ltd share is 75.00.

What is the PB ratio of Evoq Remedies Ltd Share?

Answer Field

As on Feb 27 2026 02:35 PM, the price-to-book (PB) ratio for Evoq Remedies Ltd share is 17.88.

How to Buy Evoq Remedies Ltd Share?

Answer Field

You can trade in Evoq Remedies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Evoq Remedies Ltd Share on Bajaj Broking App?

Answer Field

To buy Evoq Remedies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Evoq Remedies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59